US FDA Calls Biologic Makers to ‘INTERACT’ With New Program

글 내용 전체보기

Minakem Opens New High Containment Facility

글 내용 전체보기

FDA Approves First Cannabidiol-based Drug

글 내용 전체보기

US and EU Talk Inspections, Generics, and Advanced Therapies at Bilateral Meeting

글 내용 전체보기

Sanofi Pasteur, Translate Bio in $805-Million Deal to Develop mRNA-Based Vaccines

글 내용 전체보기

ISPE Forms Foundation to Support the Pharma Industry

글 내용 전체보기

FDA Publishes User Fee Guidance

글 내용 전체보기

EMA Modernizes Orphan Drug Process

글 내용 전체보기

CellGenix Completes First Step of Facility Expansion for Cell-Culture Reagents

글 내용 전체보기

CAR-T Firm Autolus Raises $150m in IPO

글 내용 전체보기

Canada OKs Samsung BioLogics’ mAb Drug Substance Plant

글 내용 전체보기

WuXi Pumps $20m into Conjugation and Fill/Finish Site

글 내용 전체보기

Sanofi Completes $4.8-Billion Ablynx Acquisition

글 내용 전체보기

Sartorius Pumps $100m in Puerto Rico, Doubles SU Bag and Filter Capacity

글 내용 전체보기

Roche to Acquire Foundation Medicine for $2.4 Billion

글 내용 전체보기

Congress Presses FDA to Do More to Combat Drug Shortages

글 내용 전체보기

Celltrion Resubmits to FDA Its Proposed Biosimilar to Roche’s Herceptin

글 내용 전체보기

Plant on the Road to Remediation as Celltrion Resubmits Biosimilars

글 내용 전체보기

New Immunotherapy Method Brings Complete Regression of Hard-to-Treat Breast Cancer

글 내용 전체보기

FDA Commissioner Outlines Agency’s Efforts for Patient-Focused Drug Development

글 내용 전체보기

WuXi Biologics to Build US Biologics Production Facility

글 내용 전체보기